41.64k followers • 31 symbols Watchlist by Yahoo Finance
Follow this list to discover and track the stocks that were bought the most by hedge funds in the last quarter.
Curated by Yahoo Finance
Follow this list to discover and track the stocks that were bought the most by hedge funds in the last quarter.
Background
Yahoo Finance employs sophisticated algorithms to monitor and detect trends in the global financial markets. We bring these insights to you in the form of watchlists.
Find other winning investment ideas with the Yahoo Finance Screener.
How are these weighted?The stocks in this watchlist are weighted equally.
Watchlist | Change today | 1-month return | 1-year return | Total return |
---|---|---|---|---|
Most bought by hedge funds | -2.13% | - | - | - |
^GSPC | -0.07% | +0.22% | +26.15% | +5502.91% |
Symbol | Company name | Last price | Change | % change | Market time | Volume | Avg vol (3-month) | Market cap |
---|---|---|---|---|---|---|---|---|
HDB | HDFC Bank Limited | 55.42 | +0.09 | +0.16% | 11:44 am GMT-4 | 493.40k | 2.91M | 140.45B |
TD | The Toronto-Dominion Bank | 56.72 | +0.59 | +1.05% | 11:44 am GMT-4 | 644.33k | 3.10M | 100.29B |
HPE | Hewlett Packard Enterprise Company | 17.035 | -0.02 | -0.15% | 11:44 am GMT-4 | 1.56M | 15.26M | 22.14B |
BIP | Brookfield Infrastructure Partners L.P. | 30.39 | -0.29 | -0.95% | 11:43 am GMT-4 | 77.54k | 536.07k | 14.02B |
APG | APi Group Corporation | 37.265 | -0.33 | -0.86% | 11:39 am GMT-4 | 249.59k | 1.63M | 10.22B |
NLY | Annaly Capital Management, Inc. | 19.885 | +0.05 | +0.23% | 11:44 am GMT-4 | 746.52k | 3.45M | 9.95B |
TAL | TAL Education Group | 13.5901 | -0.20 | -1.45% | 11:44 am GMT-4 | 2.70M | 6.87M | 8.68B |
AXTA | Axalta Coating Systems Ltd. | 36.15 | -0.06 | -0.17% | 11:43 am GMT-4 | 226.42k | 2.14M | 7.98B |
AS | Amer Sports, Inc. | 14.835 | +0.59 | +4.11% | 11:44 am GMT-4 | 414.13k | 1.54M | 7.50B |
ALIT | Alight, Inc. | 7.545 | -0.14 | -1.89% | 11:44 am GMT-4 | 4.75M | 5.98M | 4.26B |
BHC | Bausch Health Companies Inc. | 6.955 | +0.01 | +0.07% | 11:44 am GMT-4 | 1.12M | 3.19M | 2.55B |
ACMR | ACM Research, Inc. | 23.98 | -1.31 | -5.18% | 11:44 am GMT-4 | 750.33k | 1.74M | 1.49B |
OCUL | Ocular Therapeutix, Inc. | 5.41 | -0.43 | -7.36% | 11:44 am GMT-4 | 858.23k | 2.76M | 837.95M |
WALD | Waldencast plc | 4.83 | +0.05 | +1.05% | 11:07 am GMT-4 | 2.39k | 83.31k | 590.17M |
PWFL | PowerFleet, Inc. | 5.05 | +0.01 | +0.20% | 11:44 am GMT-4 | 162.56k | 830.41k | 544.99M |
CDMO | Avid Bioservices, Inc. | 8.355 | +0.21 | +2.64% | 11:43 am GMT-4 | 197.90k | 1.41M | 530.37M |
KALV | KalVista Pharmaceuticals, Inc. | 12.01 | -0.08 | -0.66% | 11:38 am GMT-4 | 41.96k | 761.04k | 506.68M |
EVLV | Evolv Technologies Holdings, Inc. | 2.43 | -1.41 | -36.72% | 11:44 am GMT-4 | 7.42M | 1.67M | 378.06M |
CYBN | Cybin Inc. | 0.3617 | -0.01 | -3.23% | 11:44 am GMT-4 | 992.72k | 5.23M | 274.78M |
FREY | FREYR Battery, Inc. | 1.895 | -0.08 | -3.81% | 11:44 am GMT-4 | 975.34k | 1.50M | 264.74M |
MCAA | Mountain & Co. I Acquisition Corp. | 11.56 | -0.01 | -0.09% | 4:00 pm GMT-4 | 127.00 | 82.01k | 199.56M |
STXS | Stereotaxis, Inc. | 2.195 | +0.00 | +0.23% | 11:41 am GMT-4 | 61.93k | 333.97k | 180.27M |
RGLS | Regulus Therapeutics Inc. | 2.24 | -0.01 | -0.44% | 11:39 am GMT-4 | 202.17k | 3.19M | 146.64M |
CLSD | Clearside Biomedical, Inc. | 1.23 | -0.12 | -8.89% | 11:40 am GMT-4 | 160.24k | 377.55k | 91.92M |
UONEK | Urban One, Inc. | 1.665 | +0.02 | +1.52% | 11:36 am GMT-4 | 4.19k | 65.47k | 88.01M |
FTCI | FTC Solar, Inc. | 0.504 | -0.05 | -8.41% | 11:44 am GMT-4 | 819.67k | 754.15k | 63.48M |
XAIR | Beyond Air, Inc. | 1.14 | -0.05 | -4.20% | 11:41 am GMT-4 | 199.03k | 302.99k | 52.33M |
CARA | Cara Therapeutics, Inc. | 0.73 | -0.03 | -3.96% | 11:42 am GMT-4 | 48.54k | 594.06k | 39.91M |
UNCY | Unicycive Therapeutics, Inc. | 1.0608 | -0.02 | -1.78% | 11:37 am GMT-4 | 67.85k | 414.98k | 39.89M |
KPRX | Kiora Pharmaceuticals, Inc. | 0.4937 | +0.01 | +1.40% | 11:41 am GMT-4 | 194.70k | 244.97k | 12.96M |
Phase 2 trial for KIO-301 for the treatment of retinitis pigmentosa, in partnership with Théa Open Innovation, expected to be initiated in Q4 2024Phase 2 clinical trial for KIO-104 for retinal inflammation expected to begin in 2025 Ended Q1 2024 with $31.3 million in cash and cash equivalents, providing an expected runway of more than two yearsEncinitas, California--(Newsfile Corp. - May 10, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announces ...
HELSINKI, May 10, 2024--Amer Sports, Inc. ("Amer Sports"), a global group of iconic sports and outdoor brands, announced today that it will report its first quarter 2024 financial results before the market opens on Tuesday, May 21st 2024. The company will webcast a call with management that day at 8:00 a.m. Eastern Time.
First Quarter Highlights and Recent DevelopmentsFirst quarter revenue of $12.6 millionCompany remains focused on purchase orders, operational efficiencies, quality and customer serviceTotal backlog now stands at $1.8 billionContinue to expect to achieve quarterly profitability in 2024 AUSTIN, Texas, May 10, 2024 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software and engineering services, today announced financial results for the first quarte